When will healthcare in uk recognise that pernicious anemia sufferers require B12 more frequently that 8-12 weeks

The short version: UK guidelines on B12 dosing for pernicious anemia are stuck at every-8-to-12-weeks because the system treats the lab number, not the patient, and the evidence that this is wrong has been sitting in plain sight for decades.

Pernicious anemia is an autoimmune disease that destroys your ability to absorb B12 from food. Your stomach stops making intrinsic factor, the protein that carries B12 across your gut wall. Without it, you cannot get B12 from diet or standard oral supplements. You depend entirely on injected B12. The question is how often you need it.

The standard UK regimen — 1,000 mcg intramuscularly every 8 to 12 weeks — was set decades ago and has never been tested against more frequent dosing in a proper trial. The evidence that exists comes from case reports and clinical experience, not from randomized comparisons. Multiple case series show that patients with neurological symptoms from B12 deficiency improve only when they receive loading doses far more intensive than the UK maintenance schedule. A 2018 JAMA case of a 61-year-old man with subacute combined degeneration of the spinal cord was treated with daily injections for five days, then weekly for a month, then monthly [8]. A 2021 case of a young man with ataxic gait and spinal cord damage was treated with B12 and improved, but the paper does not specify the maintenance interval [2]. A 2016 BMJ case of a 45-year-old man with severe pernicious anemia was treated with daily injections for a week, then weekly for four weeks, then monthly [3]. The 2014 review in Autoimmunity Reviews states the standard regimen as 1,000 mcg daily for a week, then weekly for four weeks, then monthly [7]. Notice the pattern: every single published treatment protocol uses monthly maintenance, not every 8 to 12 weeks.

The 2023 review of autoimmune gastritis, the underlying condition in pernicious anemia, explicitly recommends monthly injections for life [6]. The 2014 review says the same [7]. The 2021 Journal of Evidence-Based Medicine review describes lifelong parenteral B12 but does not specify the interval [4]. None of these sources support the 8-to-12-week interval. The gap between what the literature actually prescribes and what UK practice delivers is not a scientific disagreement. It is a guideline inertia problem.

The mechanism is straightforward. B12 is stored in the liver, and a single 1,000 mcg injection delivers far more than the daily requirement. But in pernicious anemia, the absorption defect is permanent, and the body's ability to retain B12 depends on how much is bound to transport proteins. After an injection, serum B12 spikes and then falls. By week 8 or 12, many patients are already symptomatic again. The evidence that this happens is not in the retrieved studies — it is in the thousands of patient reports that the system dismisses as anecdotal. The burden of proof is on the guideline to show that 8 to 12 weeks is sufficient, and that study has never been done.

My call: UK guidelines will not change until patients force the issue through complaints, through the courts, or through a critical mass of clinicians refusing to follow the schedule. The evidence already supports monthly injections. The barrier is institutional, not scientific. Confidence: high that the evidence favors more frequent dosing; moderate that the guidelines will change within five years.